Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Sevabertinib Shows Antitumour Activity in Patients with Locally Advanced or Metastatic...

Ogkologos - 14 Νοεμβρίου, 2025

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

Ogkologos - 13 Νοεμβρίου, 2025

EMA Recommends Extending Indications for Lisocabtagene Maraleucel

Ogkologos - 12 Νοεμβρίου, 2025

ESMO Launches First Congress on Artificial Intelligence and Digital Oncology: A...

Ogkologos - 12 Νοεμβρίου, 2025

Presence of Tumour and Higher Levels of LAG3-positive T-cells in the...

Ogkologos - 11 Νοεμβρίου, 2025

ESMO Calls for Cancer Care Safeguards in the EU’s Health Crisis...

Ogkologos - 11 Νοεμβρίου, 2025

PROs Support Switching to Camizestrant Plus CDK4/6 Inhibitor for HR-positive, HER2-negative...

Ogkologos - 10 Νοεμβρίου, 2025

Rucaparib Monotherapy Provides Significant and Durable Long-Term Benefit as First-Line Maintenance...

Ogkologos - 7 Νοεμβρίου, 2025

FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma

Ogkologos - 6 Νοεμβρίου, 2025

Long-Term Follow-Up Data Support Longer RFS with Adjuvant Nivolumab Than with...

Ogkologos - 5 Νοεμβρίου, 2025

1...333435...440 Σελίδα 34 από 440

MOST POPULAR

Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer

24 Ιανουαρίου, 2022

What Survivors Should Know When Transitioning From Cancer Care to Primary...

4 Απριλίου, 2023

Adjuvant Immunotherapy Approved for Some Patients with Lung Cancer

26 Οκτωβρίου, 2021

The Opioid Epidemic and Cancer Pain Management: A Conversation with Dr....

16 Ιουλίου, 2018

Φόρτωση περισσοτέρων

Sevabertinib Shows Antitumour Activity in Patients with Locally Advanced or Metastatic...

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

EMA Recommends Extending Indications for Lisocabtagene Maraleucel

ESMO Launches First Congress on Artificial Intelligence and Digital Oncology: A...

Presence of Tumour and Higher Levels of LAG3-positive T-cells in the...

ESMO Calls for Cancer Care Safeguards in the EU’s Health Crisis...

PROs Support Switching to Camizestrant Plus CDK4/6 Inhibitor for HR-positive, HER2-negative...

Rucaparib Monotherapy Provides Significant and Durable Long-Term Benefit as First-Line Maintenance...

FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma

Long-Term Follow-Up Data Support Longer RFS with Adjuvant Nivolumab Than with...

MOST POPULAR

Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer

What Survivors Should Know When Transitioning From Cancer Care to Primary...

Adjuvant Immunotherapy Approved for Some Patients with Lung Cancer

The Opioid Epidemic and Cancer Pain Management: A Conversation with Dr....

HOT NEWS

Opinion: ‘Medical research charities are falling through the cracks of COVID-19...

Adding More Mushrooms to Your Diet May Decrease Your Risk of...

Breast Cancer Centers Rarely Follow National Screening Recommendations, Study Says

Trial Results Highlight Changing Lung Cancer Treatment Landscape

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ